A detailed history of Guardian Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Guardian Wealth Advisors, LLC holds 6,687 shares of ABBV stock, worth $1.18 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
6,687
Previous 6,647 0.6%
Holding current value
$1.18 Million
Previous $1.14 Million 15.79%
% of portfolio
0.82%
Previous 0.74%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $6,553 - $7,973
40 Added 0.6%
6,687 $1.32 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $24,302 - $28,379
-157 Reduced 2.31%
6,647 $1.14 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $31,005 - $35,327
-194 Reduced 2.77%
6,804 $1.24 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $5,504 - $6,198
40 Added 0.57%
6,998 $1.08 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $534 - $618
4 Added 0.06%
6,958 $1.04 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $265 - $329
-2 Reduced 0.03%
6,954 $936,000
Q1 2023

May 18, 2023

BUY
$144.61 - $166.54 $49,890 - $57,456
345 Added 5.22%
6,956 $1.11 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $955,438 - $1.1 Million
-6,607 Reduced 99.97%
2 $0
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $348,264 - $417,660
2,518 Added 61.55%
6,609 $1.07 Million
Q3 2022

May 18, 2023

BUY
$134.21 - $153.93 $886,993 - $1.02 Million
6,609 Added 330450.0%
6,611 $887,000
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $330,827 - $379,437
-2,465 Reduced 37.6%
4,091 $549,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $3,715 - $4,723
27 Added 0.41%
6,556 $1 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $21,776 - $27,018
-165 Reduced 2.46%
6,529 $1.06 Million
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $15,899 - $20,117
148 Added 2.26%
6,694 $906,000
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $65,755 - $74,642
-618 Reduced 8.63%
6,546 $706,000
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $1.54 Million - $1.72 Million
-14,669 Reduced 67.19%
7,164 $807,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $1.49 Million - $1.64 Million
14,552 Added 199.86%
21,833 $2.36 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $2,455 - $2,702
24 Added 0.33%
7,281 $788,000
Q4 2020

May 10, 2021

BUY
$80.49 - $108.67 $584,115 - $788,618
7,257 New
7,257 $778,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Guardian Wealth Advisors, LLC Portfolio

Follow Guardian Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.